Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia

Affiliations

Hanine El Haddad: Infectious Diseases, Infection Control & Employee Health, University of Texas MD Anderson Cancer Center
Anne-Marie Chaftari: Infectious Diseases, Infection Control & Employee Health, University of Texas MD Anderson Cancer Center
Ray Hachem: Infectious Diseases, Infection Control & Employee Health, University of Texas MD Anderson Cancer Center
Majd Michael: Infectious Diseases, Infection Control & Employee Health, University of Texas MD Anderson Cancer Center
Ying Jiang: Infectious Diseases, Infection Control & Employee Health, University of Texas MD Anderson Cancer Center
Ammar Yousif: Infectious Diseases, Infection Control & Employee Health, University of Texas MD Anderson Cancer Center
Sammy Raad: Infectious Diseases, Infection Control & Employee Health, University of Texas MD Anderson Cancer Center
Mary Jordan: Infectious Diseases, Infection Control & Employee Health, University of Texas MD Anderson Cancer Center
Patrick Chaftari: Emergency Medicine, University of Texas MD Anderson Cancer Center
Issam Raad: Infectious Diseases, Infection Control & Employee Health, University of Texas MD Anderson Cancer Center

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.